162 related articles for article (PubMed ID: 38707926)
1. Qufeng tongluo decoction decreased proteinuria in diabetic mice by protecting podocytes via promoting autophagy.
Ni B; Xiao Y; Wei R; Liu W; Zhu L; Liu Y; Ruan Z; Li J; Wang S; Zhao J; Huang W
J Tradit Complement Med; 2024 May; 14(3):312-320. PubMed ID: 38707926
[TBL] [Abstract][Full Text] [Related]
2. Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.
Han J; Zhang Y; Shi X; Peng Z; Xing Y; Pang X
J Tradit Chin Med; 2021 Feb; 41(1):125-132. PubMed ID: 33522205
[TBL] [Abstract][Full Text] [Related]
3. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
Jin D; Liu F; Yu M; Zhao Y; Yan G; Xue J; Sun Y; Zhao D; Li X; Qi W; Wang X
J Ethnopharmacol; 2022 Jul; 293():115246. PubMed ID: 35398500
[TBL] [Abstract][Full Text] [Related]
4. Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.
Zhaoan G; Lina S; Yingying L; Ruifeng LI; Chong L; Ke D; Jing S; Jun S
J Tradit Chin Med; 2023 Aug; 43(4):667-675. PubMed ID: 37454251
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D Ameliorates Podocyte Injury by Enhancing Autophagy Activity in Diabetic Kidney Disease.
Zhang X; Zhang L; Wen Y; Zhang M; Liu S; Xiao H
Kidney Blood Press Res; 2023; 48(1):314-325. PubMed ID: 37054686
[TBL] [Abstract][Full Text] [Related]
6. Qingfei Tongluo Mixture Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis through mTOR-Dependent Autophagy in Rats.
Ge S; Guo Z; Xiao T; Sun P; Yang B; Ying Y
Mediators Inflamm; 2024; 2024():5573353. PubMed ID: 38361765
[TBL] [Abstract][Full Text] [Related]
7. Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose-Induced Podocyte Injury by Inhibiting the Activation of Wnt/
Dai H; Liu F; Qiu X; Liu W; Dong Z; Jia Y; Feng Z; Liu Z; Zhao Q; Gao Y; Zhang Z; Gao C; Sun S; Tian X; Liu B
Evid Based Complement Alternat Med; 2020; 2020():7809427. PubMed ID: 32963573
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative effects of Modified Huangqi Chifeng decoction on podocyte injury via autophagy mediated by PI3K/AKT/mTOR and AMPK/mTOR pathways.
Zhao M; Yin Y; Yang B; Chang M; Ma S; Shi X; Li Q; Li P; Zhang Y
J Ethnopharmacol; 2024 Mar; 321():117520. PubMed ID: 38042389
[TBL] [Abstract][Full Text] [Related]
9. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
[TBL] [Abstract][Full Text] [Related]
10. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
11. Effect of Qufengtongluo Decoction on PI3K/Akt Signaling Pathway in the Kidney of Type 2 Diabetes Mellitus Rat (GK Rat) with Diabetic Nephropathy.
Huang WJ; Fu Q; Xiao YH; Gong Q; Wu WJ; Shen ZL; Zhang H; Jia X; Huang XM; Zhang YX; Zhao JX; Wang SD; Jia M; Zhang YT
Evid Based Complement Alternat Med; 2018; 2018():8421979. PubMed ID: 29552086
[TBL] [Abstract][Full Text] [Related]
12. Qufeng Tongluo Prescription () inhibits mesangial cell proliferation and promotes apoptosis through regulating cell cycle progression.
Wu XL; An P; Ye BY; Shi XM; Sun WS; Fu RG; Wang Z; Qiao CL
Chin J Integr Med; 2013 Dec; 19(12):927-34. PubMed ID: 24307313
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol transcriptionally regulates miRNA-18a-5p expression ameliorating diabetic nephropathy via increasing autophagy.
Xu XH; Ding DF; Yong HJ; Dong CL; You N; Ye XL; Pan ML; Ma JH; You Q; Lu YB
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4952-4965. PubMed ID: 29164562
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
15. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D/vitamin D receptor/Atg16L1 axis maintains podocyte autophagy and survival in diabetic kidney disease.
Shi L; Xiao C; Zhang Y; Xia Y; Zha H; Zhu J; Song Z
Ren Fail; 2022 Dec; 44(1):694-705. PubMed ID: 35469547
[TBL] [Abstract][Full Text] [Related]
17. [Qufeng Tongluo decoction inhibits lipopolysaccharide-induced rat mesangial cell proliferation in vitro by suppressing NF-kappaB activation and reducing TGF-beta1 and IL-6 mRNA expressions].
Wang Z; Sun WS; Wang J; Ma QY; Zhang XQ; Wu XL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1825-7. PubMed ID: 18971183
[TBL] [Abstract][Full Text] [Related]
18. Lysosome restoration to activate podocyte autophagy: a new therapeutic strategy for diabetic kidney disease.
Liu WJ; Gan Y; Huang WF; Wu HL; Zhang XQ; Zheng HJ; Liu HF
Cell Death Dis; 2019 Oct; 10(11):806. PubMed ID: 31649253
[TBL] [Abstract][Full Text] [Related]
19. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
Wang Y; Peng L; Lu X; Zhang H; Zhao H; Zhao T; Yang L; Mao H; Ma F; Liu T; Li P; Zhan Y
J Ethnopharmacol; 2024 Apr; 324():117721. PubMed ID: 38199335
[TBL] [Abstract][Full Text] [Related]
20. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
